StockData
MetLife Inc logo

MetLife Inc (MET) stock

METNYSELife InsuranceFiscal year ends December 31Also trades as MET.PA, MET.PE, MET.PF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3037% above fair value
$101.50+0.05 (+0.05%)

Close on Nov 17, 2026Market cap $64.50BP/E 13.2Yield 2.21%

MetLife operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MetLife's operating cash flow for the twelve months ending Sep 30, 2026 was $13.99B, down 4.3% year over year. For fiscal 2025 it was $17.09B, up 17.1% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $17.16B in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.09B+17.1%
FY2024Dec 31, 2024$14.60B+6.4%
FY2023Dec 31, 2023$13.72B+5.2%
FY2022Dec 31, 2022$13.04B+5.6%
FY2021Dec 31, 2021$12.35B+6.1%
FY2020Dec 31, 2020$11.64B-15.6%
FY2019Dec 31, 2019$13.79B+17.4%
FY2018Dec 31, 2018$11.74B-4.4%
FY2017Dec 31, 2017$12.28B-16.9%
FY2016Dec 31, 2016$14.77B+5.1%
FY2015Dec 31, 2015$14.05B-14.2%
FY2014Dec 31, 2014$16.38B+1.5%
FY2013Dec 31, 2013$16.13B-6.0%
FY2012Dec 31, 2012$17.16B+67.0%
FY2011Dec 31, 2011$10.27B+28.7%
FY2010Dec 31, 2010$7.99B+110.0%
FY2009Dec 31, 2009$3.80B-64.5%
FY2008Dec 31, 2008$10.70B+8.1%
FY2007Dec 31, 2007$9.90B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.00B-43.9%
Q2 FY2026Jun 30, 2026$2.23B+1.9%
Q1 FY2026Mar 31, 2026$2.69B-37.0%
Q4 FY2025Dec 31, 2025$7.08B+53.5%
Q3 FY2025Sep 30, 2025$3.57B-14.4%
Q2 FY2025Jun 30, 2025$2.19B-37.3%
Q1 FY2025Mar 31, 2025$4.26B+83.1%
Q4 FY2024Dec 31, 2024$4.61B-11.0%
Q3 FY2024Sep 30, 2024$4.17B+20.0%
Q2 FY2024Jun 30, 2024$3.49B+14.9%
Q1 FY2024Mar 31, 2024$2.33B+14.9%
Q4 FY2023Dec 31, 2023$5.18B+125.2%
Q3 FY2023Sep 30, 2023$3.48B-19.4%
Q2 FY2023Jun 30, 2023$3.04B-30.8%
Q1 FY2023Mar 31, 2023$2.03B-0.7%
Q4 FY2022Dec 31, 2022$2.30B-54.8%
Q3 FY2022Sep 30, 2022$4.31B+22.9%
Q2 FY2022Jun 30, 2022$4.39B+94.9%
Q1 FY2022Mar 31, 2022$2.04B+36.4%
Q4 FY2021Dec 31, 2021$5.09B-1.2%
Q3 FY2021Sep 30, 2021$3.51B-7.6%
Q2 FY2021Jun 30, 2021$2.25B+166.4%
Q1 FY2021Mar 31, 2021$1.50B-19.0%
Q4 FY2020Dec 31, 2020$5.15B-0.5%
Q3 FY2020Sep 30, 2020$3.79B-8.5%
Q2 FY2020Jun 30, 2020$846.00M-64.6%
Q1 FY2020Mar 31, 2020$1.85B-10.9%
Q4 FY2019Dec 31, 2019$5.18B+298.2%
Q3 FY2019Sep 30, 2019$4.15B+17.4%
Q2 FY2019Jun 30, 2019$2.39B-57.4%
Q1 FY2019Mar 31, 2019$2.07B+59.9%
Q4 FY2018Dec 31, 2018$1.30B-36.5%
Q3 FY2018Sep 30, 2018$3.53B-25.4%
Q2 FY2018Jun 30, 2018$5.61B+64.9%
Q1 FY2018Mar 31, 2018$1.30B-38.2%
Q4 FY2017Dec 31, 2017$2.05B-63.7%
Q3 FY2017Sep 30, 2017$4.73B–
Q2 FY2017Jun 30, 2017$3.40B–
Q1 FY2017Mar 31, 2017$2.10B–
Q4 FY2016Dec 31, 2016$5.64B–

More MetLife figures

See a number that looks wrong?